Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study (Q36877022)
Jump to navigation
Jump to search
scientific article published on 9 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study |
scientific article published on 9 June 2008 |
Statements
1 reference
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study (English)
1 reference
Everett E Vokes
1 reference
Ezra E W Cohen
1 reference
Lee S Rosen
1 reference
Merrill S Kies
1 reference
Arlene A Forastiere
1 reference
Francis P Worden
1 reference
Madeleine A Kane
1 reference
Eric Sherman
1 reference
Sinil Kim
1 reference
Paul Bycott
1 reference
Michael Tortorici
1 reference
David R Shalinsky
1 reference
Katherine F Liau
1 reference
Roger B Cohen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference